Biogen Announces Voluntary Drug Withdrawal and Pfizer Drug Acquisition Weeks Apart, Share Price Remains Steady
3D Printing Investing Organovo Announces Fiscal Second-Quarter 2017 Results; Company Affirms Full-Year Fiscal 2017 and Long-Range Outlook
Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee
Finlay Minerals Appoints an Executive Chairman, President & CEO, and Vice President, Corporate Development
